Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Selectively Replicating Adenoviruses for Oncolytic Therapy

Volume:1   Issue: 2
Pp: 85-107
Tack-Kee Laurent Yoon, Toshiaki Shichinohe, Sylvie Laquerre and Noriyuki Kasahara
DOI: 10.2174/1568009013334223

Selective Destruction of Tumor Cells through Specific Inhibition of Products Resulting from Chromosomal Translocations

Volume:1   Issue: 2
Pp: 109-119
A. Rodriguez-Garcia, M. Sanchez-Martin, J. Perez-Losada, P. A. Perez-Mancera, A. Sagrera-Aparisi, N. Gutierrez-Cianca, C. Cobaleda and I. Sanchez-Garcia
DOI: 10.2174/1568009013334214

Mutant Cell Surface Receptors as Targets for Individualized Cancer Diagnosis and Therapy

Volume:1   Issue: 2
Pp: 121-128
Karl-Friedrich Becker and Heinz Hofler
DOI: 10.2174/1568009013334205

Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents

Volume:1   Issue: 2
Pp: 129-140
Sutapa Ghosh, Xing-Ping Liu, Yaguo Zheng and Fatih M. Uckun
DOI: 10.2174/1568009013334188

Thymidine Phosphorylase: A Two-Face Janus in Anticancer Chemotherapy

Volume:1   Issue: 2
Pp: 141-153
F. Focher and S. Spadari
DOI: 10.2174/1568009013334232

Microarrays: Spotlight on Gene Function and Pharmacogenomics

Volume:1   Issue: 2
Pp: 155-175
M. Nees and C. D. Woodworth
DOI: 10.2174/1568009013334197